Loading fund overlap…
14 of 119 unique stocks in common · Jaccard: 11.8%
A weighted portfolio overlap of 23.17% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹23.17 is allocated to the exact same companies at the same relative proportions. The schemes share 14 common holdings.
The largest overlapping asset in their portfolios is HDFC Bank, which commands a weight of 6.36% in SBI Large and Midcap Fund and 7.94% in Tata Large & Mid Cap Fund. Holding both schemes increases your concentration in HDFC Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in SBI | in Tata |
|---|---|---|
| HDFC BankBanks | 6.36% | 7.94% |
| ICICI BankBanks | 3.98% | 4.35% |
| State Bank of IndiaBanks | 2.88% | 5.80% |
| Bharat ForgeAuto Components | 2.34% | 2.84% |
| United BreweriesBeverages | 1.77% | 1.80% |
| Abbott IndiaPharmaceuticals & Biotechnology | 1.88% | 1.35% |
| The Ramco CementsCement & Cement Products | 0.98% | 1.83% |
| Adani Energy SolutionsPower | 0.91% | 1.69% |
| InfosysIT - Software | 0.94% | 0.68% |
| SBI Cards & Payment ServicesFinance | 0.47% | 3.86% |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | 1.86% | 0.44% |
| ACCCement & Cement Products | 0.41% | 1.86% |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 1.86% | 0.34% |
| Tata Motors Passenger VehiclesAutomobiles | 0.26% | 0.84% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.